Home›People›Fred Ehrsam
Fred Ehrsam

Fred Ehrsam

Director and 10% owner at Coinbase Global. Also a director at Yuva Biosciences and an executive officer at Paradigm.

InvestorDirectorPublic companyParadigm
Updated Nov 10, 2026·Latest SEC filing Jun 18, 2026·Suggest an edit

About Fred Ehrsam

Fred Ehrsam is a director and 10% owner at Coinbase Global.

Form D filings name Fred Ehrsam as a director at Yuva Biosciences.

Fred Ehrsam reports to the SEC as a director or major shareholder of 1 public company.

Fred Ehrsam appears on fund filings for Paradigm.

Fred Ehrsam first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Fred Ehrsam in the role, so the role may have started earlier or lasted longer.

Coinbase Global, Inc.
Director and 10% owner
2021 – 2026 · Public company (COIN)
Yuva Biosciences, Inc.
Director
2026 · Birmingham, AL
Discovers compounds for consumer brands and biotechnology companies using AI and mitochondrial research.
Paradigm
Executive officer
2021 – 2022 · Fund filings for 1 fund

Key Colleagues at Startups

The people Fred Ehrsam works with at each company, as listed on that company's latest Form D.

Yuva Biosciences, Inc. · Form D, Mar 24, 2026
Greg Schmergel
Greg Schmergel
Co-Founder and CEO, director

Sources

  1. SECYuva Biosciences, Inc. Form D, filed Mar 24, 2026
  2. SECForms 3, 4 and 5 filed by Fred Ehrsam (SEC filer 1851442)